Living donor kidney transplantation: Let's talk about it.

Chronic kidney disease end-stage renal disease kidney transplantation living donation organ donation

Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
05 2020
Historique:
entrez: 17 5 2020
pubmed: 18 5 2020
medline: 15 5 2021
Statut: ppublish

Résumé

Transplantation is the preferred treatment option for end-stage renal disease as it offers superior results and patient reported outcomes in comparison to dialysis. Patients treated with a transplant live longer, healthier and more independent lives. Transplantation is also more cost-effective, reducing the overall burden of renal disease. Despite the rising incidence of renal failure, the uptake of living donor kidney transplantation has been static across the UK for several years. Among transplantation, living donation offers a number of advantages compared with deceased donor transplantation. The procedure is more likely to be performed pre-dialysis and the elective nature allows for better perioperative planning. Awareness for living donation processes among healthcare professionals, patients and the public appears to be poor. Sharing information regarding the process will help educate colleagues, dispel myths and, crucially, allow patients the opportunity to talk about this treatment option with their hospital doctor.

Identifiants

pubmed: 32414729
pii: 20/3/346
doi: 10.7861/clinmed.2020-0047
pmc: PMC7354017
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

346-348

Informations de copyright

© Royal College of Physicians 2020. All rights reserved.

Références

Transplantation. 2002 Nov 27;74(10):1377-81
pubmed: 12451234
Kidney Int. 2014 Jul;86(1):162-7
pubmed: 24284516
Nephron. 2020;144(2):59-66
pubmed: 31825944
Am J Transplant. 2007 Oct;7(10):2326-32
pubmed: 17845566
Transplantation. 2012 Apr 15;93(7):666-73
pubmed: 22456484
Kidney Int. 1996 Jul;50(1):235-42
pubmed: 8807593
Bull World Health Organ. 2018 Jun 1;96(6):414-422D
pubmed: 29904224
Nat Clin Pract Nephrol. 2007 Jan;3(1):31-41
pubmed: 17183260
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1518-1527
pubmed: 28818845
Nephrol Dial Transplant. 2017 Feb 1;32(2):216-223
pubmed: 28186535
Transplantation. 2018 Jun;102(6):961-968
pubmed: 29215463
J Am Soc Nephrol. 2005 Jun;16(6):1859-65
pubmed: 15857921
J Am Soc Nephrol. 1998 Nov;9(11):2135-41
pubmed: 9808102

Auteurs

Videha Sharma (V)

Manchester University Hospitals NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK videha.sharma@postgrad.manchester.ac.uk.

Reuben Roy (R)

Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

Oana Piscoran (O)

Manchester University Hospitals NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK.

Angela Summers (A)

Manchester University Hospitals NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK.

David van Dellen (D)

Manchester University Hospitals NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK.

Titus Augustine (T)

Manchester University Hospitals NHS Foundation Trust, Manchester, UK and University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH